| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-10 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.23 | 6e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-09 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-09 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-08 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-08 |